Cairo Pharmaceuticals
Cairo Pharmaceuticals operates in various business sectors.
Market Cap & Net Worth: Cairo Pharmaceuticals (CPCI)
Cairo Pharmaceuticals (EGX:CPCI) has a market capitalization of $46.54K (EGP2.35 Million) as of March 18, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #42443 globally and #15 in its home market, demonstrating a 0.32% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cairo Pharmaceuticals's stock price EGP251.83 by its total outstanding shares 9343 (9.34K).
Cairo Pharmaceuticals Market Cap History: 2015 to 2026
Cairo Pharmaceuticals's market capitalization history from 2015 to 2026. Data shows growth from $1.17K to $46.54K (42.03% CAGR).
Cairo Pharmaceuticals Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cairo Pharmaceuticals's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CPCI by Market Capitalization
Companies near Cairo Pharmaceuticals in the global market cap rankings as of March 18, 2026.
Key companies related to Cairo Pharmaceuticals by market ranking:
- ELRINGKLINGER N (ZIL2.SG) (STU:ZIL2): Ranked #42434 globally with a market cap of $46.63K USD ( €45.43K EUR).
- Abans Electricals PLC (CM:ABANN0000): Ranked #42435 globally with a market cap of $46.60K USD ( SLRs13.59 Million LKR).
- SANTOS (STS1.SG) (STU:STS1): Ranked #42444 globally with a market cap of $46.38K USD ( €45.18K EUR).
- Schloss Bangalore Ltd (NSE:THELEELA): Ranked #42445 globally with a market cap of $46.35K USD ( ₹4.01 Million INR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #42434 | ELRINGKLINGER N (ZIL2.SG) | STU:ZIL2 | $46.63K | €4.62 |
| #42435 | Abans Electricals PLC | CM:ABANN0000 | $46.60K | SLRs1388.75 |
| #42444 | SANTOS (STS1.SG) | STU:STS1 | $46.38K | €4.57 |
| #42445 | Schloss Bangalore Ltd | NSE:THELEELA | $46.35K | ₹407.85 |
Cairo Pharmaceuticals Historical Marketcap From 2015 to 2026
Between 2015 and today, Cairo Pharmaceuticals's market cap moved from $1.17K to $ 46.54K, with a yearly change of 42.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | EGP46.54K | -5.00% |
| 2025 | EGP48.98K | +172.66% |
| 2024 | EGP17.97K | +71.92% |
| 2023 | EGP10.45K | +15.15% |
| 2022 | EGP9.08K | +41.16% |
| 2021 | EGP6.43K | -4.13% |
| 2020 | EGP6.71K | -7.38% |
| 2019 | EGP7.24K | -5.59% |
| 2018 | EGP7.67K | +129.84% |
| 2017 | EGP3.34K | +130.37% |
| 2016 | EGP1.45K | +23.94% |
| 2015 | EGP1.17K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cairo Pharmaceuticals was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $46.54K USD |
| MoneyControl | $46.54K USD |
| MarketWatch | $46.54K USD |
| marketcap.company | $46.54K USD |
| Reuters | $46.54K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.